Long non‑coding RNA AL355711 promotes smooth muscle cell migration through the ABCG1/MMP3 pathway

Kang,Chun-Min; Li,Wei-Kang; Yu,Ke-Wei; Li,Xue-Heng; Huang,Rui-Ying; Ke,Pei-Feng; Jin,Xing; Cao,Shun-Wang; Yuan,Ying-Shi; Wang,Heng; Yan,Jun; Chen,Wei-Ye; Huang,Xian-Zhang; Zhao,Jing-Jing

doi:10.3892/ijmm.2021.5040

Long non‑coding RNA AL355711 promotes smooth muscle cell migration through the ABCG1/MMP3 pathway

Authors:
- Chun-Min Kang
- Wei-Kang Li
- Ke-Wei Yu
- Xue-Heng Li
- Rui-Ying Huang
- Pei-Feng Ke
- Xing Jin
- Shun-Wang Cao
- Ying-Shi Yuan
- Heng Wang
- Jun Yan
- Wei-Ye Chen
- Xian-Zhang Huang
- Jing-Jing Zhao
View Affiliations

Affiliations: Department of Laboratory Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, P.R. China, Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China
Published online on: October 1, 2021 https://doi.org/10.3892/ijmm.2021.5040
Article Number: 207
Copyright: © Kang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Atherosclerosis and related cardiovascular diseases pose severe threats to human health worldwide. There is evidence to suggest that at least 50% of foam cells in atheromas are derived from vascular smooth muscle cells (VSMCs); the first step in this process involves migration to human atherosclerotic lesions. Long non‑coding RNAs (lncRNAs) have been found to play significant roles in diverse biological processes. The present study aimed to investigate the role of lncRNAs in VSMCs. The expression of lncRNAs or mRNAs was detected using reverse transcription‑quantitative polymerase chain reaction. The Gene Expression Omnibus datasets in the NCBI portal were searched using the key words ‘Atherosclerosis AND tissue AND Homo sapiens’ and the GSE12288 dataset. Gene expression in circulating leukocytes was measured to identify patients with coronary artery disease (CAD) or controls, and used to analyze the correlation coefficient and expression profiles. The protein level of ATP‑binding cassette sub‑family G member 1 (ABCG1) and matrix metalloproteinase (MMP)3 was determined using immunohistochemistry and western blot analysis. The analysis of mouse aortic roots was performed using Masson's and Oil Red O staining. The expression of lncRNA AL355711, ABCG1 and MMP3 was found to be higher in human atherosclerotic plaques or in patients with atherosclerotic CAD. The correlation analysis revealed that ABCG1 may be involved in the regulation between lncRNA AL355711 and MMP3 in atherosclerotic CAD. The knockdown of lncRNA AL355711 inhibited ABCG1 transcription and smooth muscle cell migration. In addition, lncRNA AL355711 was found to regulate MMP3 expression through the ABCG1 pathway. The expression of ABCG1 and MMP3 was found to be high in an animal model of atherosclerosis. The results indicated that lncRNA AL355711 promoted VSMC migration and atherosclerosis partly via the ABCG1/MMP3 pathway. On the whole, the present study demonstrates that the inhibition of lncRNA AL355711 may serve as a novel therapeutic target for atherosclerosis. lncRNA AL355711 in circulating leukocytes may be a novel biomarker for atherosclerotic CAD.

View Figures

View References

1	Zhao D, Liu J, Wang M, Zhang X and Zhou M: Epidemiology of cardiovascular disease in China: Current features and implications. Nat Rev Cardiol. 16:203–212. 2019. View Article : Google Scholar
2	Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, Tokgözoğlu L and Lewis EF: Atherosclerosis. Nat Rev Dis Primers. 5:562019. View Article : Google Scholar : PubMed/NCBI
3	Vasan RS and Benjamin EJ: The future of cardiovascular epidemiology. Circulation. 133:2626–2633. 2016. View Article : Google Scholar : PubMed/NCBI
4	Pan H, Xue C, Auerbach BJ, Fan J, Bashore AC, Cui J, Yang DY, Trignano SB, Liu W, Shi J, et al: Single-cell genomics reveals a novel cell state during smooth muscle cell phenotypic switching and potential therapeutic targets for atherosclerosis in mouse and human. Circulation. 142:2060–2075. 2020. View Article : Google Scholar : PubMed/NCBI
5	Xu S, Kamato D, Little PJ, Nakagawa S, Pelisek J and Jin ZG: Targeting epigenetics and non-coding RNAs in atherosclerosis: From mechanisms to therapeutics. Pharmacol Ther. 196:15–43. 2019. View Article : Google Scholar :
6	Simion V, Zhou H, Haemmig S, Pierce JB, Mendes S, Tesmenitsky Y, Pérez-Cremades D, Lee JF, Chen AF, Ronda N, et al: A macrophage-specific lncRNA regulates apoptosis and atherosclerosis by tethering HuR in the nucleus. Nat Commun. 11:61352020. View Article : Google Scholar : PubMed/NCBI
7	Guo FX, Wu Q, Li P, Zheng L, Ye S, Dai XY, Kang CM, Lu JB, Xu BM, Xu YJ, et al: The role of the LncRNA-FA2H-2-MLKL pathway in atherosclerosis by regulation of autophagy flux and inflammation through mTOR-dependent signaling. Cell Death Differ. 26:1670–1687. 2019. View Article : Google Scholar :
8	Wu G, Cai J, Han Y, Chen J, Huang ZP, Chen C, Cai Y, Huang H, Yang Y, Liu Y, et al: LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity. Circulation. 130:1452–1465. 2014. View Article : Google Scholar :
9	Mahmoud AD, Ballantyne MD, Miscianinov V, Pinel K, Hung J, Scanlon JP, Iyinikkel J, Kaczynski J, Tavares AS, Bradshaw AC, et al: The human-specific and smooth muscle cell-enriched LncRNA SMILR promotes proliferation by regulating mitotic CENPF mRNA and drives cell-cycle progression which can be targeted to limit vascular remodeling. Circ Res. 125:535–551. 2019. View Article : Google Scholar : PubMed/NCBI
10	Dong XH, Lu ZF, Kang CM, Li XH, Haworth KE, Ma X, Lu JB, Liu XH, Fang FC, Wang CS, et al: The long noncoding RNA RP11-728F11.4 promotes atherosclerosis. Arterioscler Thromb Vasc Biol. 41:1191–1204. 2021. View Article : Google Scholar : PubMed/NCBI
11	Hu YW, Guo FX, Xu YJ, Li P, Lu ZF, McVey DG, Zheng L, Wang Q, Ye JH, Kang CM, et al: Long noncoding RNA NEXN-AS1 mitigates atherosclerosis by regulating the actin-binding protein NEXN. J Clin Invest. 129:1115–1128. 2019. View Article : Google Scholar :
12	Bai HL, Lu ZF, Zhao JJ, Ma X, Li XH, Xu H, Wu SG, Kang CM, Lu JB, Xu YJ, et al: Microarray profiling analysis and validation of novel long noncoding RNAs and mRNAs as potential biomarkers and their functions in atherosclerosis. Physiol Genomics. 51:644–656. 2019. View Article : Google Scholar : PubMed/NCBI
13	Kang CM, Bai HL, Li XH, Huang RY, Zhao JJ, Dai XY, Zheng L, Qiu YR, Hu YW and Wang Q: The binding of lncRNA RP11-732M18.3 with 143-3 β/α accelerates p21 degradation and promotes glioma growth. EBioMedicine. 45:58–69. 2019. View Article : Google Scholar :
14	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
15	Ponting CP, Oliver PL and Reik W: Evolution and functions of long noncoding RNAs. Cell. 136:629–641. 2009. View Article : Google Scholar : PubMed/NCBI
16	Wang Y, Dubland JA, Allahverdian S, Asonye E, Sahin B, Jaw JE, Sin DD, Seidman MA, Leeper NJ and Francis GA: Smooth muscle cells contribute the majority of foam cells in ApoE (Apolipoprotein E)-deficient mouse atherosclerosis. Arterioscler Thromb Vasc Biol. 39:876–887. 2019. View Article : Google Scholar : PubMed/NCBI
17	Guizani I, Zidi W, Zayani Y, Boudiche S, Hadj-Taieb S, Sanhaji H, Zaroui A, Mechmeche R, Mourali MS, Feki M and Allal-Elasmi M: Matrix metalloproteinase-3 predicts clinical cardiovascular outcomes in patients with coronary artery disease: A 5 years cohort study. Mol Biol Rep. 46:4699–4707. 2019. View Article : Google Scholar : PubMed/NCBI
18	Galis ZS, Sukhova GK, Lark MW and Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 94:2493–2503. 1994. View Article : Google Scholar : PubMed/NCBI
19	Johnson JL, Dwivedi A, Somerville M, George SJ and Newby AC: Matrix metalloproteinase (MMP)-3 activates MMP-9 mediated vascular smooth muscle cell migration and neointima formation in mice. Arterioscler Thromb Vasc Biol. 31:e35–e44. 2011. View Article : Google Scholar : PubMed/NCBI
20	Du X, Patel A, Anderson CS, Dong J and Ma C: Epidemiology of cardiovascular disease in China and opportunities for improvement: JACC international. J Am Coll Cardiol. 73:3135–3147. 2019. View Article : Google Scholar
21	Libby P, Bornfeldt KE and Tall AR: Atherosclerosis: Successes, surprises, and future challenges. Circ Res. 118:531–534. 2016. View Article : Google Scholar : PubMed/NCBI
22	Allahverdian S, Chaabane C, Boukais K, Francis GA and Bochaton-Piallat ML: Smooth muscle cell fate and plasticity in atherosclerosis. Cardiovasc Res. 114:540–550. 2018. View Article : Google Scholar : PubMed/NCBI
23	Liu Y, Cui X, Wang C and Zhao S: LncRNA HCG11 regulates proliferation and apoptosis of vascular smooth muscle cell through targeting miR-144-3p/FOXF1 axis in atherosclerosis. Biol Res. 53:442020. View Article : Google Scholar :
24	Tang R, Mei X, Wang YC, Cui XB, Zhang G, Li W and Chen SY: LncRNA GAS5 regulates vascular smooth muscle cell cycle arrest and apoptosis via p53 pathway. Biochim Biophys Acta Mol Basis Dis. 1865:2516–2525. 2019. View Article : Google Scholar : PubMed/NCBI
25	Zhang Z, Zou G, Chen X, Lu W, Liu J, Zhai S and Qiao G: Knockdown of lncRNA PVT1 inhibits vascular smooth muscle cell apoptosis and extracellular matrix disruption in a murine abdominal aortic aneurysm model. Mol Cells. 42:218–227. 2019.PubMed/NCBI
26	Subramaniam N, Nair R and Marsden PA: Epigenetic regulation of the vascular endothelium by angiogenic LncRNAs. Front Genet. 12:6683132021. View Article : Google Scholar :
27	Wang YQ, Xu ZM, Wang XL, Zheng JK, Du Q, Yang JX and Zhang HC: LncRNA FOXC2-AS1 regulated proliferation and apoptosis of vascular smooth muscle cell through targeting miR-1253/FOXF1 axis in atherosclerosis. Eur Rev Med Pharmacol Sci. 24:3302–3314. 2020.
28	Kumar MM and Goyal R: LncRNA as a therapeutic target for angiogenesis. Curr Top Med Chem. 17:1750–1757. 2017. View Article : Google Scholar :
29	Yu AM, Choi YH and Tu MJ: RNA drugs and RNA targets for small molecules: Principles, progress and challenges. Pharmacol Rev. 72:862–898. 2020. View Article : Google Scholar : PubMed/NCBI
30	Johnson JL: Metalloproteinases in atherosclerosis. Eur J Pharmacol. 816:93–106. 2017. View Article : Google Scholar : PubMed/NCBI
31	Monaco C, Gregan SM, Navin TJ, Foxwell BM, Davies AH and Feldmann M: Toll-like receptor-2 mediates inflammation and matrix degradation in human atherosclerosis. Circulation. 120:2462–2469. 2009. View Article : Google Scholar
32	Hu W, Wei R, Wang L, Lu J, Liu H and Zhang W: Correlations of MMP-1, MMP-3, and MMP-12 with the degree of atherosclerosis, plaque stability and cardiovascular and cerebrovascular events. Exp Ther Med. 15:1994–1998. 2018.PubMed/NCBI
33	Ma L and Zhang L, Wang B, Wei J, Liu J and Zhang L: Berberine inhibits Chlamydia pneumoniae infection-induced vascular smooth muscle cell migration through downregulating MMP3 and MMP9 via PI3K. Eur J Pharmacol. 755:102–109. 2015. View Article : Google Scholar : PubMed/NCBI
34	Seifi M, Fallah S and Firoozrai M: Influence of genetic polymorphism in matrix metalloproteinase-3 on extent of coronary atherosclerosis and risk of coronary artery stenosis. Arch Med Res. 40:600–604. 2009. View Article : Google Scholar
35	Kraen M, Frantz S, Nihlén U, Engström G, Löfdahl CG, Wollmer P and Dencker M: Matrix metalloproteinases in COPD and atherosclerosis with emphasis on the effects of smoking. PLoS One. 14:e02119872019. View Article : Google Scholar : PubMed/NCBI
36	Kaplan RC, Smith NL, Zucker S, Heckbert SR, Rice K and Psaty BM: Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke. Atherosclerosis. 201:130–137. 2008. View Article : Google Scholar : PubMed/NCBI
37	Alexander MR, Moehle CW, Johnson JL, Yang Z, Lee JK, Jackson CL and Owens GK: Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice. J Clin Invest. 122:70–79. 2012. View Article : Google Scholar :